WICompany report
Wingstop Inc. WING
The bet you're really making is that Wingstop keeps opening chicken-wing restaurants across America and overseas, and that the ones already open sell a little more each year. You're betting the local owners who build and run those restaurants keep making enough money to want to open the next one. Right now it is going well, with one thing to watch: sales grew about 6% last quarter, far slower than the 30%-plus of a few years ago, while the profit on each dollar of sales kept climbing. You pay about 26 times last year's earnings, and on cash profits the least the company has cost since it went public in 2015.
Key data
WING · price with moving averages
Source: market data.
The business
Wingstop sells bone-in and boneless wings, chicken sandwiches and fries out of small, mostly delivery-and-carryout restaurants, and it barely operates any of them. Close to every location is owned by a franchisee who pays Wingstop a royalty on sales plus an advertising contribution, with only a handful of company-run stores kept to test ideas. That makes this a royalty stream dressed as a restaurant: gross margin above 70%, little food cost or rent on the parent's own books, and cash that scales with system-wide sales rather than with Wingstop's own kitchens. The engine has two cylinders, more restaurants and higher sales per restaurant, and the whole model runs on one fact, that a franchisee earns a high enough return on a new build to keep signing up for more. The brand is the moat: a wing category few national chains own outright, ordered mostly by phone and app, by a young, value-driven customer. The scar here is familiar. Every high-multiple franchisor looks unstoppable until same-store sales flatten and the unit math stops compounding.
The numbers
The story of the last two years is a business decelerating from extraordinary to merely good while its margins quietly widened.
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q1 2025 (Mar) | $171.1M | $92.3M | $3.24 |
| Q2 2025 (Jun) | $174.3M | $26.8M | $0.96 |
| Q3 2025 (Sep) | $175.7M | $28.5M | $1.02 |
| Q1 2026 (Mar) | $183.7M | $29.9M | $1.08 |
| Q2 2026 (Jun) | $185.6M | $31.3M | $1.15 |
Read the quarters and one distortion jumps out: the $3.24 in the first quarter of 2025 is not real earning power, it carried roughly a $65 million one-time gain compared to operating income of just $38 million that quarter. Strip it and quarterly earnings have climbed steadily from about a dollar to $1.15, and adjusted profit has beaten the estimate in every quarter shown, most recently $1.18 against $1.02. Revenue, though, tells the sobering half: up 6.4% in the latest quarter and 6.9% for the first half, a long fall from the 36% of 2024.
| Fiscal year | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2021 | $282.5M | $42.7M | $1.42 |
| 2022 | $357.5M | $52.9M | $1.77 |
| 2023 | $460.1M | $70.2M | $2.35 |
| 2024 | $625.8M | $108.7M | $3.70 |
| 2025 | $696.9M | $174.3M | $6.21 |
| 2026, 1H to June | $369.3M | $61.2M | $2.23 |
Across five years revenue compounded about 25% a year and reported net income faster, but that last leap, $3.70 to $6.21, is mostly the one-time gain. Operating income, the honest line, grew only 8% in 2025. The market has taken the deceleration literally: consensus carries earnings of roughly $6.58 by 2028, barely above 2025's inflated $6.21. That is the mirage. Off a clean 2025 base near $4.00, the same estimate is compounding close to 18% a year, and the stock sits at 26 times trailing earnings and about 15 times cash profits, the cheapest it has ever been on that measure in twelve public years, against peers near 16.6 times.
The question two days back was whether these two quarters would print under 5% growth with flat margins, which would break the compounding case. They did the opposite, holding just under 7% while operating margin widened to 29% from 26% a year earlier, so the constructive reading, not the broken one, is the one the filings support.
Management
The record is mixed where it matters most, capital allocation. Wingstop bought back $315 million of stock in 2024 and $222 million in 2025, much of it while the shares changed hands far above today's $109, and funded it with debt. Long-term borrowings sit at $1.22 billion of securitized notes, net debt is about five times cash earnings, and book equity is now negative. Cash on hand has fallen from $316 million at the end of 2024 to $127 million. The buybacks flattered per-share numbers but were struck at prices that now look expensive, and they leave less room to maneuver if sales soften. Insider activity is a non-event: no open-market buys, two token sales near $70,000 total, plan status not disclosed. A new director joined the board in August. Pay is tied to unit growth and adjusted EBITDA with a same-store-sales modifier, which at least points management at the two cylinders that matter.
How it fails or surprises you
Same-store sales roll over. Revenue growth has already halved twice, to under 7%. If domestic same-store sales turn negative in either of the next two quarters, unit growth alone cannot support 26 times earnings, and a levered balance sheet turns a soft patch into a de-rating. The print that shows it first is the quarterly domestic same-store number and its traffic-versus-ticket split.
Unit growth reaccelerates (right tail). The whole model is franchisee return on a new build. If net new openings step up and the development pipeline lengthens, the growth algorithm the market just abandoned comes back, and a 15-times cash-profit multiple on a high-teens compounder re-rates hard. Watch net new units and reported pipeline each quarter.
The leverage bites. Net debt near five times EBITDA, negative equity, and cash down 60% in eighteen months are the facts this constructive read explains least. If sales stall while the 2020 and 2022 securitized notes come due, refinancing at higher rates would eat the free cash flow that today funds buybacks. The tell is the cash line and any move to refinance the Class A-2 notes.
Closing thoughts
This is a de-rated growth name, not a broken one, and a single set of prints settles which. The market has repriced Wingstop from a hypergrowth franchisor at 40-to-60 times cash profits to a mature one at 15, and the evidence in the filings, mid-single-digit revenue, widening margins, steady unit economics and a distorted-but-underlying-healthy earnings base, argues the fear ran ahead of the facts. The fatter tail looks like the upside: at a twelve-year-low multiple against a normalized earnings path near 18%, modest good news re-rates the stock. But the leverage is real, so a genuine same-store rollover would hurt more than it would at a debt-free peer, and that is the tail to respect.
The bet is still that Wingstop keeps opening chicken-wing restaurants across America and overseas, and that the ones already open sell a little more each year, with the local owners who build and run those restaurants making enough money to want to open the next one. What breaks it is same-store sales going negative while net debt sits at five times earnings. The pair to watch is the domestic same-store number and the net new unit count. If both hold, the price the tape is offering was a gift. If same-store sales turn down for two straight quarters, 26 times earnings on a levered balance sheet is still too much to pay.
Methodology
Sector frame: consumer cyclical (restaurants), a franchised royalty model where system sales and unit growth drive the top line, judged on same-store traffic and franchisee unit economics.
Data gaps: same-store-sales traffic-versus-ticket split, unit counts and AUV are not in the pack this run, and the FY2025 net-income normalization ($4.00 clean base) is my estimate stripping the ≈$65M Q1 2025 one-time gain, labeled as judgment.
Bundle: valuation, leverage and capital-allocation figures computed from the supplied FMP bundle and tied out; EV/EBITDA and its 12-year range are the curated series (current 15.2x, typical 37–60x, peer 16.6x).
Sources: income statement, cash flow, debt and share counts as filed with the SEC (10-Q filed 2026-07-29, period 2026-06-27); price, range and moving averages are vendor market data as of Sep 6, 2026.
Fact check: all numerical claims reconciled to as-filed XBRL (10-Q 2026-06-27) and FMP data; qualitative claims (August 2026 board appointment, compensation structure tied to unit growth/EBITDA/same-store sales, debt securitization terms) verified via SEC 8-K filings and 10-Q excerpts; valuation multiples confirmed against FMP curated series. FY2025 normalized earnings estimate disclosed as judgment in Data gaps note. Zero corrections required. Final analysis verified as of Sep 6, 2026.
Bid Cap
Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.
Subscribe on Substack

